About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Texas | 655 Studies

Clinical Trials Pancreatic CancerTexas

Pancreatic Cancer Clinical Trials in Texas

Find 655 clinical trials for pancreatic cancer near Texas. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 301-320 of 655 trials

CompletedTrial of Curcumin in Advanced Pancreatic CancerThe goal of this clinical research study is to learn if treatment with curcumin can help shrink or slow the growth of pancreatic cancers.NCT00094445·Houston, Texas CompletedLEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)The purpose of this signal seeking study was to determine whether treatment with LEE011 demonstrates sufficient efficacy in CDK4/6 pathway activated solid tumors and/or…NCT02187783·Birmingham, Alabama and 60 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedA Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer PatientsThe objectives of this study are: * To determine the safety and MTD of CPI-613, when used in combination with Gemcitabine, in cancer patients.NCT00907166·The Bronx, New York and 1 other

TerminatedARQ-761 Treatment With Gemcitabine/Nab-Paclitaxel Chemotherapy In Pancreatic CancerThis is a study of ARQ-761 (beta-lapachone) with gemcitabine/nab-paclitaxel chemotherapy in subjects with advanced (metastatic, unresectable, or recurrent) pancreatic cancer that…NCT02514031·Baltimore, Maryland and 1 other

RecruitingStudy of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid TumorsThis is an open label, multi-center, multiple dose Phase 1 study to evaluate the safety, tolerability, MTD PK, and PD of TJ033721 (givastomig) in subjects with advanced or…NCT04900818·Orange, California and 20 others

CompletedPhase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic CancerThe purpose of this research study is to determine the effects and toxicity of gemcitabine alone or gemcitabine plus enzastaurin in participants with pancreatic cancer.NCT00267020·Dallas, Texas

CompletedPerifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic CancerRATIONALE: Perifosine may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth.NCT00059982·Urbana, Illinois and 9 others

CompletedA SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic CancerChemotherapy regimens for pancreatic cancer can now stabilize a patient's cancer and/or place some patients in remission or partial remission.NCT03331562·Scottsdale, Arizona and 5 others

TerminatedAn Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced MalignanciesThis was a study of INCB054329 given to patients with advanced malignancies that were conducted in three treatment groups.NCT02431260·Los Angeles, California and 11 others

CompletedPhase II Trial Of Gemcitabine Plus Nab-Paclitaxel +/- OGX-427 In Patients With Metastatic Pancreatic CancerThe purpose of this study is to compare the overall survival in patients with previously untreated metastatic pancreatic cancer receiving gemcitabine/nab-paclitaxel plus OGX-427…NCT01844817·San Francisco, California and 10 others

CompletedPhase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC)This clinical study is in subjects who are 18 years old or older with locally advanced pancreatic cancer who have not received prior treatment for their pancreatic cancer.NCT02301143·Scottsdale, Arizona and 41 others

CompletedCCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerDrugs used in chemotherapy, such as CCI-779, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00075647·Houston, Texas

CompletedA Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic CancerThe purpose of this study is to determine whether an investigational immuno-therapy, cabiralizumab in combination with nivolumab, with or without chemotherapy, is effective for…NCT03336216·Phoenix, Arizona and 40 others

CompletedSafety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2The purpose of this study is to investigate a safe dose of TAK-165, once daily (QD), in patients with HER2-tumor expression.NCT00034281·Scottsdale, Arizona and 3 others

CompletedChemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic CancerThis pilot clinical trial studies combination chemotherapy and radiation therapy before surgery followed by gemcitabine hydrochloride in treating patients with pancreatic cancer.NCT01821612·La Jolla, California and 13 others

TerminatedA Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin LymphomaThe purpose of this phase 2 study is to evaluate the efficacy and safety of NIR178 in combination with PDR001 in multiple solid tumors and diffuse large B-cell lymphoma (DLBCL)…NCT03207867·Santa Monica, California and 20 others

RecruitingA Phase 2 Study of Zanidatamab in Patients With HER2-expressing TumorsThe purpose of this study is to evaluate the efficacy and safety of zanidatamab for the treatment of participants with previously treated solid tumors that have Human Epidermal…NCT06695845·Prescott, Arizona and 27 others

RecruitingA Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid TumorsThis is a first-in-human (FIH), multicenter, open-label Phase I study to investigate the safety, tolerability, preliminary antitumor activity, as well as pharmacokinetics (PK) and…NCT05932862·Fountain Valley, California and 15 others

UnknownSafety and Efficacy Study of DCVax-Direct in Solid TumorsThe study comprises a Phase I component during which the optimal dose of DCVax-Direct for the treatment of solid tissue tumors will be identified, followed by a Phase II component…NCT01882946·Orlando, Florida and 1 other

CompletedPhase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic CancerThe goal of this study is to determine the safety and efficacy of a chemotherapy regimen known as Modified FOLFIRINOX (mFFX) alone or with the addition of Stereotactic Body…NCT01926197·Los Angeles, California and 8 others

PreviousPage 16 of 33Next

Other Conditions in Texas

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia